Researchers have been excited about the medication , a novel dual agonist showing significant data in clinical trials for size reduction . It acts by modulating two hormones : GLP-1 and GIP, these, when https://shaniaueak638947.blogrenanda.com/47642909/this-new-possibility-for-size-management